Lymphoid Neoplasm — Research

Lymphoid Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-26	524	`("Lymphoid Neoplasm"[tiab])`	2026-09-26	pubmed
Last 5 years	2021-01-01 → 2026-12-31	213	`("Lymphoid Neoplasm"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-26	pubmed
Preceding 5-year window	2020-09-26 → 2025-09-25	186	`("Lymphoid Neoplasm"[tiab]) AND (2020/09/26:2025/09/25[dp])`	2026-09-26	pubmed
Last 12 months	2025-09-26 → 2026-09-26	41	`("Lymphoid Neoplasm"[tiab]) AND (2025/09/26:2026/09/26[dp])`	2026-09-26	pubmed
y2016	2016-01-01 → 2016-12-31	19	`("Lymphoid Neoplasm"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-26	pubmed
y2017	2017-01-01 → 2017-12-31	18	`("Lymphoid Neoplasm"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-26	pubmed
y2018	2018-01-01 → 2018-12-31	20	`("Lymphoid Neoplasm"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-26	pubmed
y2019	2019-01-01 → 2019-12-31	18	`("Lymphoid Neoplasm"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-26	pubmed
y2020	2020-01-01 → 2020-12-31	23	`("Lymphoid Neoplasm"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-26	pubmed
y2021	2021-01-01 → 2021-12-31	35	`("Lymphoid Neoplasm"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-26	pubmed
y2022	2022-01-01 → 2022-12-31	49	`("Lymphoid Neoplasm"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-26	pubmed
y2023	2023-01-01 → 2023-12-31	51	`("Lymphoid Neoplasm"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-26	pubmed
y2024	2024-01-01 → 2024-12-31	38	`("Lymphoid Neoplasm"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-26	pubmed
y2025	2025-01-01 → 2025-12-31	34	`("Lymphoid Neoplasm"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-26	pubmed

Data updated 5 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (317)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 226–250 of 317 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group.
· Blood · 2017 · PMID 28408464 · validated civic_curation pubmed
Larotrectinib in TRK fusion-positive pediatric B-cell acute lymphoblastic leukemia.
· Blood Adv · 2019 · PMID 31725893 · validated civic_curation pubmed
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
· Nat Genet · 2015 · PMID 26214592 · validated civic_curation pubmed
Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion.